Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin M Ellingson

Showing results (231-240 of 286) with videos related to

Pageof 29
Sort By:
The Lancet. Oncology|November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working groupHideho Okada, Michael Weller, Raymond Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2023
Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent GlioblastomaBenjamin M Ellingson, Akifumi Hagiwara, Connor J Morris, et al.
Neuro-Oncology Advances|May 2, 2023
Retrospective examination of pseudoprogression in <i>IDH</i> mutant gliomasEthan A Wetzel, Matthew J Farrell, Blaine S C Eldred, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2021
Modified RANO, Immunotherapy RANO, and Standard RANO Response to Convection-Enhanced Delivery of IL4R-Targeted Immunotoxin MDNA55 in Recurrent GlioblastomaBenjamin M Ellingson, John Sampson, Achal Singh Achrol, et al.
Neuro-Oncology Advances|April 15, 2024
Single-nucleus expression characterization of non-enhancing region of recurrent high-grade gliomaKunal S Patel, Kaleab K Tessema, Riki Kawaguchi, et al.
AJNR. American Journal of Neuroradiology|May 30, 2026
Tumor Growth Rate (TGR) Analysis Predicts Survival in a Multicenter Phase II Study of the PARP Inhibitor Pamiparib (BGB-290) with Temozolomide in Recurrent IDH-Mutant Gliomas (ABTC-1801)Benjamin M Ellingson, Timothy F Cloughesy, Xiaobu Ye, et al.
NMR in Biomedicine|June 15, 2022
Amine-weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumorsNicholas S Cho, Akifumi Hagiwara, Jingwen Yao, et al.
Neuro-Oncology|January 9, 2025
A Hitchhiker's Guide Toward CSF Biomarkers for Neuro-OncologyCecile Riviere-Cazaux, Michael B Keough, Jeffrey A Zuccato, et al.
Neuro-Oncology|December 18, 2019
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II studyAndrew J Brenner, Katherine B Peters, James Vredenburgh, et al.
Plos One|October 14, 2015
Unique Microstructural Changes in the Brain Associated with Urological Chronic Pelvic Pain Syndrome (UCPPS) Revealed by Diffusion Tensor MRI, Super-Resolution Track Density Imaging, and Statistical Parameter Mapping: A MAPP Network Neuroimaging StudyDavis Woodworth, Emeran Mayer, Kevin Leu, et al.
Pageof 29

Showing results (231-240 of 286) with videos related to

Sort By:
Pageof 29
The Lancet. Oncology|November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working groupHideho Okada, Michael Weller, Raymond Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2023
Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent GlioblastomaBenjamin M Ellingson, Akifumi Hagiwara, Connor J Morris, et al.
Neuro-Oncology Advances|May 2, 2023
Retrospective examination of pseudoprogression in <i>IDH</i> mutant gliomasEthan A Wetzel, Matthew J Farrell, Blaine S C Eldred, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2021
Modified RANO, Immunotherapy RANO, and Standard RANO Response to Convection-Enhanced Delivery of IL4R-Targeted Immunotoxin MDNA55 in Recurrent GlioblastomaBenjamin M Ellingson, John Sampson, Achal Singh Achrol, et al.
Neuro-Oncology Advances|April 15, 2024
Single-nucleus expression characterization of non-enhancing region of recurrent high-grade gliomaKunal S Patel, Kaleab K Tessema, Riki Kawaguchi, et al.
AJNR. American Journal of Neuroradiology|May 30, 2026
Tumor Growth Rate (TGR) Analysis Predicts Survival in a Multicenter Phase II Study of the PARP Inhibitor Pamiparib (BGB-290) with Temozolomide in Recurrent IDH-Mutant Gliomas (ABTC-1801)Benjamin M Ellingson, Timothy F Cloughesy, Xiaobu Ye, et al.
NMR in Biomedicine|June 15, 2022
Amine-weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumorsNicholas S Cho, Akifumi Hagiwara, Jingwen Yao, et al.
Neuro-Oncology|January 9, 2025
A Hitchhiker's Guide Toward CSF Biomarkers for Neuro-OncologyCecile Riviere-Cazaux, Michael B Keough, Jeffrey A Zuccato, et al.
Neuro-Oncology|December 18, 2019
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II studyAndrew J Brenner, Katherine B Peters, James Vredenburgh, et al.
Plos One|October 14, 2015
Unique Microstructural Changes in the Brain Associated with Urological Chronic Pelvic Pain Syndrome (UCPPS) Revealed by Diffusion Tensor MRI, Super-Resolution Track Density Imaging, and Statistical Parameter Mapping: A MAPP Network Neuroimaging StudyDavis Woodworth, Emeran Mayer, Kevin Leu, et al.
Pageof 29